Meet our team
Dr. Larry Gold
- Founder and former CEO and Chairman of the Board of SomaLogic
- Founder, NeXagen/NeXstar (acquired by Gilead)
- Co-founder, Synergen (acquired by Amgen)
- Professor, Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder (Chair, 1988-1992)
- BS Yale University, PhD University of Connecticut
Dr. John Swindle
- Head of Research at Rare Disease Sciences
- Cofounder, President, and CEO of CompleGen, a small molecule drug discovery company
- Associate professor, University of Washington Department of Pathobiology; member of Seattle Biomedical Research Institute
- Associate professor of Microbiology and Immunology at the University of Tennessee (1986-1996)
- BS University of Oregon, PhD University of Utah